Ultragenyx Pharmaceutical
RARE
RARE
221 hedge funds and large institutions have $4.03B invested in Ultragenyx Pharmaceutical in 2022 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 84 increasing their positions, 73 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
16% less capital invested
Capital invested by funds: $4.79B → $4.03B (-$764M)
24% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 46
Holders
221
Holding in Top 10
1
Calls
$12.6M
Puts
$14.7M
Top Buyers
| 1 | +$62.3M | |
| 2 | +$46.4M | |
| 3 | +$36.4M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$31M |
| 5 |
State Street
Boston,
Massachusetts
|
+$30.3M |
Top Sellers
| 1 | -$78.7M | |
| 2 | -$65.9M | |
| 3 | -$17.8M | |
| 4 |
O
OrbiMed
New York
|
-$16.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$14.5M |